Redmile Group »

Entrada Therapeutics shares owned by Redmile Group

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Redmile Group from 13F filings

Historical chart of Redmile Group investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by Redmile Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by Redmile Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $19M 1.3M 15.09
2023-09-30 $20M 1.3M 15.80
2023-06-30 $20M 1.3M 15.14
2023-03-31 $27M 1.8M 14.50
2022-12-31 $25M 1.9M 13.52
2022-09-30 $31M 2.0M 15.76
2022-06-30 $24M 2.0M 12.18
2022-03-31 $18M 2.0M 9.39
2021-12-31 $34M 2.0M 17.12